Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

158.50
Delayed Data
As of Jul 25
 +0.30 / +0.19%
Today’s Change
89.76
Today|||52-Week Range
276.19
+6.13%
Year-to-Date
Vertex (VRTX) to Report Q2 Earnings: Is a Surprise in Store?
Jul 25 / Zacks.com - Paid Partner Content
4 Rock-Solid, Cheap Biotech Stocks
Jul 16 / MotleyFool.com - Paid Partner Content
Amgen (AMGN) May Beat Q2 Earnings: Will the Stock Gain?
Jul 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close158.20
Today’s open157.78
Day’s range155.29 - 159.40
Volume283,626
Average volume (3 months)602,502
Market cap$3.9B
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-78.47%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book6.41

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc+0.60+1.84%
ENDPEndo International P...+0.21+1.20%
ACADACADIA Pharmaceutica...-0.24-0.66%
PTHNPatheon NV-0.39-1.54%
Data as of 07/25/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$3.74
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer
Sandip Kapadia
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs